PPD

On this #WorldAIDSDay, we reflect on the collective global effort that has transformed HIV from a deadly, unresolvable disease in the 1980s to a more manageable condition for many people today. But our work is far from over. We remain focused on improving the lives of those living with HIV – with the ultimate goal of a cure in mind – by continuing to support delivery of new therapies and emerging treatment and prevention options. 📰 » https://bit.ly/3B2E3vQ

Proactive planning is essential for optimizing late-stage #ophthalmic #clinicaltrials. In this article, our ophthalmic experts observe the #ophthalmology #drugdevelopment landscape, explore challenges of late-stage retina trials and outline strategies for enhancing study efficiency. 📥 Download now » https://bit.ly/4gBog76

Our Bulgaria site plays a crucial role in Thermo Fisher Scientific's success as one of the largest hubs, with more than 1,900 dedicated colleagues across 25 departments and 80 groups. The Sofia office is steadily expanding and boasts extensive expertise in key areas, such as Clinical Operations, Pharmacovigilance, Medical Communications, Project Management, Centralized Services, Finance, Legal, IT, HR and Talent Acquisition. With over 50% growth in the last five years, we welcome talented professionals from a variety of backgrounds to join our teams. Learn more ▶️ https://bit.ly/3B0Id7l #LifeAtThermoFisher #BulgariaJobs

In the latest issue of American Pharmaceutical Review, Rosa Rodríguez and Davide Garrisi discuss the likelihood of a future market for biosimilar versions of CAR-T therapies.

Discover the perspective of Travis Hardin, an executive director on our #respiratory and #infectiousdisease team, as he discusses his role in supporting clients with their asset development. ➠ https://bit.ly/3vMMloS

Explore the future of clinical trials. Access our on-demand webinar and discover how patient-first approaches are revolutionizing the industry. In this webinar, you'll learn about patient #recruitment strategies, how to enhance #patient engagement and the benefits of a patient-first approach. Gain insights from industry experts and stay ahead in the evolving landscape of #clinicalresearch.

The #FSP model is transforming the #biotech industry by providing additional capabilities, resources and expertise to augment internal capabilities, improve efficiency, foster #innovation and drive faster #drugdevelopment. Dive into our latest blog to explore real-world examples and insights on how FSP engagements help biotech companies stay dynamic, flexible and agile to meet their timelines. ⬇️

November is #NationalHealthySkinMonth! We leverage our extensive experience in clinical #dermatology research to drive advancements in treatments and improve outcomes for skin diseases. Partner with our dermatology experts to discover how we can achieve healthier skin together. » https://bit.ly/418hSz7

We're feeling grateful for the insightful discussions and innovative presentations at #ACR24 in Washington, D.C. 🌟 When rheumatology comes together, it’s not just inspiring — it’s transformative. We're excited to see how new partnerships and projects will shape the future of the field!

📅 Save the dates! We’re excited to return to San Francisco in the new year for the 43rd annual J.P. Morgan Healthcare Conference on Jan. 13-16. Let’s ensure your clinical development and funding strategies are aligned. 📧 Email Chelsea.Arthurs@ppd.com to schedule a meeting with our team. #JPM2025 #JPM25